Nebulized arformoterol, a long-acting β2-adrenergic bronchodilator, in patients with COPD.

被引:0
|
作者
Baumgartner, Rudolf A. [1 ]
Hanrahan, John P. [1 ]
Sciarappa, Kenneth [1 ]
机构
[1] Sepracor Inc, Marlborough, MA USA
关键词
D O I
10.1097/00003246-200612002-00329
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
348
引用
收藏
页码:A95 / A95
页数:1
相关论文
共 50 条
  • [1] Arformoterol -: The first nebulized long-acting beta2-adrenergic agonist
    Abdelghany, Osama
    Merl, Man-Yee
    FORMULARY, 2007, 42 (02) : 99 - +
  • [2] Alternative mechanisms for long-acting β2-adrenergic agonists in COPD
    Johnson, M
    Rennard, S
    CHEST, 2001, 120 (01) : 258 - 270
  • [3] EFFICACY OF NEBULIZED ARFORMOTEROL FOR THE TREATMENT OF PATIENTS WITH COPD: A ROLE FOR LONG-ACTING BRONCHODILATORS IN TREATING LONG-TERM CARE PATIENTS WITH COPD
    Sharma, Sanjay
    Ozol-Godfrey, Ayca
    Goodin, Thomas
    Price, Barry
    Sanjar, Shahin
    CHEST, 2019, 156 (04) : 461A - 462A
  • [4] Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized TreatmentOf COPD
    Donohue, James F.
    Mahler, Donald A.
    Sethi, Sanjay
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 2947 - 2958
  • [5] β2-Adrenergic Receptor Haplotype may be Associated with Susceptibility to Desensitization to Long-Acting β2-Agonists in COPD Patients
    Mochizuki, Hideaki
    Nanjo, Yuta
    Kawate, Eriko
    Yamazaki, Mariko
    Tsuda, Yasunari
    Takahashi, Hideki
    LUNG, 2012, 190 (04) : 411 - 417
  • [6] β2-Adrenergic Receptor Haplotype may be Associated with Susceptibility to Desensitization to Long-Acting β2-Agonists in COPD Patients
    Hideaki Mochizuki
    Yuta Nanjo
    Eriko Kawate
    Mariko Yamazaki
    Yasunari Tsuda
    Hideki Takahashi
    Lung, 2012, 190 : 411 - 417
  • [7] Combined long-acting bronchodilator single therapy for COPD
    Rajnoveanu, Ruxandra Mioara
    Antoniu, Sabina
    Ulmeanu, Ruxandra
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (01) : 139 - 142
  • [8] Bronchodilator treatment of stable COPD: long-acting anticholinergics
    Vincken, W.
    EUROPEAN RESPIRATORY REVIEW, 2005, 14 (94): : 23 - 31
  • [9] Long-Acting Bronchodilator Use in the Management of Stable COPD
    Abukwaik, Aya Wail
    Mansukhani, Rupal
    Bridgeman, Mary Barna
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (06) : 562 - 570
  • [10] Do long-acting β2-adrenergic agonists deserve a different place in guidelines for the treatment of asthma and COPD?
    van Schayck, CP
    EUROPEAN RESPIRATORY JOURNAL, 2000, 15 (04) : 631 - 634